The Life Sciences Business Template Library

Foundation models + wet-lab loop for hit ID and optimization.

Design proteins from scratch for therapeutics or enzymes.

Extract structured RWE from clinical notes, path, imaging reports.

Human genetics + functional genomics to nominate targets.

Cloud pipelines for sequencing, single-cell, spatial, proteomics.

Combine imaging + omics + clinical for patient-specific models.

Companion or livestock drugs; faster/cheaper path than human.

In-clinic and reference lab tests for pets and livestock.

ctDNA-based cancer detection and monitoring.

IVD assays paired with targeted therapies.

CLIA-waived rapid tests for clinics, pharmacies, home.

Genome + proteome + metabolome + microbiome DTC/clinical.

Slide-scanning + AI diagnostic assistance.

Deep learning on CT/MR/X-ray for triage and detection.

Panel and exome testing for inherited disease.

cfDNA screening for aneuploidy and microdeletions.

Multiplex PCR/NGS for respiratory, GI, sepsis, meningitis.

Troponin + ECG + BNP + wearable rhythm.

Comprehensive genomic profiling for oncology and rare disease.

Vertical telehealth (dermatology, mental health, hormones).

Software-only therapy with clinical evidence and prescriber workflow.

Vertical EHR for a specific specialty (behavioral, dental, fertility, oncology).

AI-powered coding, prior auth, denials management.

Ambient LLM scribe for clinic visits.

Therapy + med management + coaching at scale.

Chronic condition RPM (HTN, diabetes, HF, COPD).

Full-risk primary care for Medicare Advantage / ACO REACH.

Focused benefit (musculoskeletal, fertility, diabetes, cancer, obesity).

eConsent + eCOA + wearables + televisit + logistics.

Screen + refer + close-the-loop on food, housing, transport.

Fertility, maternity, menopause, pelvic floor, gynecology.

Microbial production of proteins, lipids, cosmetics.

Meat, seafood, dairy alternatives.

Bioplastics, mycelium leather, spider-silk fiber, algal foams.

Engineered organisms fixing CO2 into chemicals or fuels.

Custom enzymes for detergents, textiles, biofuels, food.

Sustainable aviation fuel and next-gen biodiesel.

Gene-edited or transgenic crop traits (yield, drought, disease).

Sustainable feed, disease genomics, RAS systems.

Biopesticides, biostimulants, microbial soil products.

Iterative device improvement in an existing category.

Life-sustaining implants: pacemakers, stents, neurostim.

Robotic assistance for MIS in soft-tissue, ortho, or endoluminal.

Implantable/wearable neurostim or brain-computer interfaces.

Continuous physiologic monitoring (CGM, ECG, SpO2, BP).

IOLs, retinal implants, glaucoma MIGS, laser platforms.

Joint replacement, spine, trauma implants, robotic assistance.

Clear aligners, dental implants, chairside CAD/CAM, AI radiography.

OTC hearing (post-2022 rule) and premium implantable hearing.

Skin substitutes, NPWT, biologics for chronic wounds.

Auto-injectors, pumps, transdermal, inhalation.

Focused CRO (bioanalytical, oncology, rare disease, cell/gene).

Biologics, cell/gene, mRNA, or small-mol contract manufacturing.

Remote-execution wet-lab experiments over API.

Cloud ELN + LIMS + inventory for modern R&D orgs.

Reagent marketplace + cold-chain shipping tech.

Evidence-based supplements, functional foods, personalized nutrition.

Peptides, growth factors, exosomes for topical use.

Clinical longevity services + aging-focused therapeutics.

Microgravity crystallization, stem cells, tissue engineering.

Novel drugs, materials, ingredients from marine organisms.

Vaccines, antivirals, decon tech for CBRN threats.

DNA phenotyping, genealogy, rapid DNA for law enforcement.

Recovery, injury prevention, elite performance analytics.

Novel chemistry against undruggable targets (PROTACs, molecular glues, allosteric binders).

Fully-human mAbs against validated targets using phage/yeast display.

Site-specific conjugation with novel linkers and payloads.

Engineered T-cells for hematologic and solid tumors.

One-time genetic correction for monogenic disease.

Programmable RNA therapeutics with novel delivery.

CRISPR/base/prime editing for genetic disease.

Rapid-response vaccine platform (mRNA, protein subunit, VLP).

Alpha/beta emitters conjugated to tumor-targeting ligands.

Defined bacterial consortia as prescription therapeutics.

Personalized phage cocktails for MDR infections.

Novel psilocybin/MDMA/ketamine analogs for TRD, PTSD, addiction.

Cost-reduced versions of expiring biologics.

Repurposed or novel drugs for <10K patient populations.